← Open Payments lookup

SARAH COMBS: Open Payments

NPI 1134630452 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,337 in 55 payments from 15 companies in 2025. Trend: 2023 $650 · 2024 $781 · 2025 $1,337

Food & beverage: $1,337
CompanyPaymentsAmount
Janssen Biotech, Inc.5$309
ABBVIE INC.16$275
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$238
Madrigal Pharmaceuticals2$80
Takeda Pharmaceuticals U.S.A., Inc.3$68
Gilead Sciences, Inc.3$60
Phathom Pharmaceuticals, Inc.3$55
Intercept Pharmaceuticals, Inc.2$55
Ardelyx, Inc.2$45
Lilly USA, LLC2$42

Products named: TREMFYA, XIFAXAN, RINVOQ, REZDIFFRA, MAVYRET, LINZESS, VOQUEZNA, OCALIVA.

Industry payments across PA — which companies pay providers there.